NUMIF (Numinus Wellness) Shares Buyback Ratio %: 0.00 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Numinus Wellness Shares Buyback Ratio %?

Numinus Wellness NUMIF +9.10% Shares Buyback Ratio % is 0.00 as of Jul. 27, 2026.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Numinus Wellness's current shares buyback ratio was 0.00%.

Numinus Wellness Shares Buyback Ratio % Related Terms

Numinus Wellness Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Numinus Wellness's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numinus Wellness Shares Buyback Ratio % Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Shares Buyback Ratio %
Get a 7-Day Free Trial -32.97 -111.87 -26.18 -3.99 -20.30

Numinus Wellness Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Numinus Wellness Shares Buyback Ratio % Calculation

Numinus Wellness's Shares Buyback Ratio for the fiscal year that ended in Aug. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Aug. 2023 ) - Shares Outstanding (EOP) (A: Aug. 2024 )) / Shares Outstanding (EOP) (A: Aug. 2023 )
=(266.455 - 320.552) / 266.455
=-20.30%

Numinus Wellness's Shares Buyback Ratio for the quarter that ended in May. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Feb. 2025 ) - Shares Outstanding (EOP) (A: May. 2025 )) / Shares Outstanding (EOP) (A: Feb. 2025 )
=(320.552 - 320.552) / 320.552
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of 0.00 mean?
Numinus Wellness (NUMIF) has a Shares Buyback Ratio % of 0.00 as of Jul. 27, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Numinus Wellness and its competitors.
Is Numinus Wellness' Shares Buyback Ratio % too high?
Numinus Wellness' current Shares Buyback Ratio % is 0.00.
How does Numinus Wellness' Shares Buyback Ratio % compare to HLYK and SYRA?
Numinus Wellness' Shares Buyback Ratio % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Healthcare Providers & Services company?
A good Shares Buyback Ratio % depends on the Healthcare Providers & Services industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Numinus Wellness and its competitors. Numinus Wellness's current Shares Buyback Ratio % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Shares Buyback Ratio % of 0.00. The current Shares Buyback Ratio % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Shares Buyback Ratio % is 0.00 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numinus Wellness Business Description

Address 801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.